Bibliography (14):

1. https://www.theguardian.com/business/article/2024/jun/25/ozempic-novo-nordisk-us-north-carolina-wegovy

2. https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2024/novo-nordisk-annual-report-2023.pdf#page=29

3. https://www.tevapharm.com/news-and-media/latest-news/teva-confirms-generic-victoza-patent-challenge-in-the-united-states/

4. https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/nvo-20221231.htm

5. https://www.fiercepharma.com/special-reports/top-10-drugs-losing-us-exclusivity-2024

6. Wikipedia Bibliography:

   1. Liraglutide

   2. Semaglutide

   3. Type 2 diabetes

   4. Novo Nordisk

   5. https://en.wikipedia.org/wiki/Teva_Pharmaceutical_Industries  :

      https://en.wikipedia.org/wiki/Teva_Pharmaceutical_Industries

   6. https://en.wikipedia.org/wiki/Hikma_Pharmaceuticals%27  :

      https://en.wikipedia.org/wiki/Hikma_Pharmaceuticals%27

   7. Eli Lilly

   8. Tirzepatide

   9. Retatrutide